The accuracy of intraoperative frozen section of the inguinal sentinel lymph node in vulvar cancer

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 4091-4094

  Brunner, Andreas H ^a   Polterauer, Stephan ^a   Tempfer, Clemens ^a   Joura, Elmar ^a   Reinthaller, Alexander ^a   Horvat, Reinhard ^b   Hefler, Lukas ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Frozen section analysis; Sentinel lymph node dissection; Vulvar cancer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; VULVA CANCER;

EID: 58149160024     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Franklin EW and Rutledge FD: Epidemiology of epidermoid carcinoma of the vulva. Obstet Gynecol 39: 165-172, 1972.
2. Messing MJ, Prasad CJ, Silva EG, Rutledge FN, Mc Arthur MC and Crum CP: Carcinoma of the vulva in young woman. Obstet Gynecol 6: 51-54, 1995.
3. Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L and Gilks CB: Vulvar squamous cell carcinoma in young women: a clinicophathologic study of 21 cases. Gynecol Oncol 84: 94-101, 2002.
4. Turner RR, Ollila DW, Krasne DL and Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271-276, 1997.
5. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39: 456-466, 1977.
6. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK and Gershenson DM: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83: 276-281, 2001.
7. Merisio C, Berretta R and Gualdi M: Radio-guided sentinel lymph node detection in vulvar cancer. Int J Gyecol Cancer 15: 493-497, 2005.
8. Gershenwald JE, Mansfield, Lee JE and Ross MI: Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma. Ann Surg Oncol 7: 160-165, 2000.
9. Morton DL, Cochran AJ, Thompson JF, Elashoff R, EssnerR, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ and Wang HJ: Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242: 302-311, 2005.
10. Borgstein PJ, Meijer S, Pijpers RJ and van DP: Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Echos from the past and the periareolar blue method. Ann Surg 232: 81-89, 2000.
11. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC and Young DC: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissecton for breast cancer. Am J Surg 183: 23-27, 2002.
12. Dardarian TS, Gray HJ, Morgan MA, Rubin SC and Randall TC: Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol 101: 140-142, 2006.
13. Coleman RL, Frumovitz M and Levenback CF: Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw 4: 471-478, 2006.
14. Adib T and Barton DP: The sentinel lymph node: relevance in gynaecological cancers. Eur J Surg Oncol 32: 866-874, 2006.
15. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G and Covens A: Sentinel node in vulvar cancer. Cancer 110: 1015-1023, 2007.
16. 99. Int J Gynecol Cancer 17: 147-153, 2007.
17. Morgan MA and Mijtta JJ: Surgical management of vulvar cancer. Surg Oncol 17: 168-172, 1999.
18. Terada YK, Shimizu DM and Wong JH: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76: 40-44, 2000.
19. Puig Tintore LM, Ordi J, Vidal Sicart S, Lejarcegui JA, Tome A, Pahisa J and Iglesias X: Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 88: 29-34, 2003.
20. Dowlatatshahi K, Anderson JM and Bloom KJ: Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 8: 675-681, 2001.
21. Pendas S, Dauway E, Cox CE, Giuliano NN and Schreiber RH: Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 65: 500-505, 1999.
22. Zhang PJ, Reisner RM, Nangia R, Edge SB and Brooks JJ: Effectveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer. Arch Pathol Lab Med 122: 687-690, 1998.
23. De Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, Boonstra H and van der Zee AG: Sentinel lymph node identification with technetium-99m-labelled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 39: 1381-1385, 1998.
24. Terada KY, Shimizu DM, Jiang CS and Wong JH: Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol 102: 200-203, 2006.
25. De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, Maggioni A, Bocciolone L, Mangioni C, Colombo N and Paganelli G: Sentinel node biopsy in early vulvar cancer. Br J Cancer 82: 295-299, 2000.
26. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, Aalders JG and van de Zee AG: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18: 2797-2799, 2000.
27. Sliutz G, Reinthaller A, Lantsch T, MendeT, Sinzinger H, Kainz C and Koelbl H: Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 84: 449-452, 2002.
28. Moore RG, De Paquale SE, Steinhoff MM, Gajewski W, Steller M, Noto R and Falkenberry S: Sentinel node identification and the ability to dedect metastatic tumor to inguinal lymph nodes in squamous cell cancer of vulva. Gyn Oncol 89: 475-479, 2003.
29. Moore RG, Granai CO, Gajewski W, Gordinier ME and Steinhoff MM: Pathologic evaluation of inguinal sentinel nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultra-staging with hematoxylin and eosin staining. Gynecol Oncol 91: 378-382, 2003.
30. Hakam A, Nasir A, Raghuwanshi R, Smith PV, Crawley S, Kaiser HE, Grendys E and Fiorica JF: Value of multilevel sectioning for improved detection of micrometastasis in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res 24: 1281-1286, 2004.
31. de Mascarel I, MacGrogan G, Picot V and Mathoulin-Pelissier S: Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients. Br J Cancer 87: 70-74, 2002.
32. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Benett IC, Wright RG: Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73: 88-95, 1996.
33. Hacker NF, Berek JS, Lagasse LD, Leuchter RS and Moore JG: Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61: 408-412, 1983.